Better Context → Better Decisions

Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers without corporate access will find a wealth of contextualized life science insight ready to be purchased in the FENIX Marketplace. If our content sharing limitations are inconvenient for you, reach out to Brady for unlimited corporate, institutional, or individual access.

astrazeneca cover image

Posted in: SGLT2i Aug 30 | 2020DAPA-CKD Results Highly Positive; AZ Winning in SGLT2i LCM Purchase Blast

lilly and BI cover image

Posted in: SGLT2i Aug 29 | 2020EMPEROR-Reduced Similarly Positive to DAPA-HF Purchase Blast

Posted in: Basal Insulin Aug 27 | 2020Lannett To Forego Bs-Glargine U100 Interchangeability; Lannett Q2 '20 Earnings Update Purchase Blast

medtronic cover image

Posted in: Glucose Monitoring, Insulin Delivery Aug 25 | 2020Medtronic CY Q2 ’20 (FY Q1 ’21) Earnings Update Purchase Blast

novartis cover image

Posted in: Autologous, CAR-T, CD19 Aug 25 | 2020Kymriah Sales Unaffected By COVID-19, but Ph3 Adult ALL Trial Withdrawn; Novartis Q2 2020 Earnings Update Purchase Blast

Posted in: Glucose Monitoring, Other Aug 24 | 2020Bayer Commits ~$100M in One Drop Series C Purchase Blast

Posted in: Glucose Monitoring, Other Aug 21 | 2020One Drop Launches New Membership Program; AZ Partners with RenalytixAI for Chronic Disease Precision Medicine Purchase Blast

Posted in: Glucose Monitoring, Other Aug 20 | 2020Sensyne to Launch New Diabetes Remote Monitoring Software Purchase Blast

Posted in: Glucagon Aug 20 | 2020FDA Warns Xeris for Misleading Gvoke DTC Purchase Blast

janssen cover image

Posted in: SGLT2i Aug 19 | 2020Invokana Boxed Warning Removed Purchase Blast

novo and evotec cover image

Posted in: Other Aug 18 | 2020Novo Signs New CKD Development Deal with Evotec Purchase Blast

european medicines agency cover image

Posted in: Basal Insulin, Bolus Insulin, DPP-IVi, Glucagon Aug 18 | 2020AZ to Withdraw Qtrilmet Marketing Authorization; CHMP Agenda August 17-20 Purchase Blast

lilly cover image

Posted in: Dual/triple agonist Aug 18 | 2020Lilly's Next-gen Tirzepatide for Oral Delivery? New Lilly GIP/GLP Dual Agonist Ph1 Studies Purchase Blast

novo cover image

Posted in: Basal Insulin, Bolus Insulin, GLP-1RA, GLP-1RA + Basal, Other Aug 14 | 2020Novo Invests in Upgrading Kalundborg Manufacturing Facility Purchase Blast

zealand cover image

Posted in: Glucagon Aug 13 | 2020Glucagon: Dasiglucagon Bi-hormonal Closed-Loop Pivotal Trial Delayed; Zealand Q2 '20 Earnings Update Purchase Blast

Posted in: Glucose Monitoring, Other Aug 12 | 2020DarioHealth Q2 '20 Earnings Update Purchase Blast

Posted in: Other Aug 12 | 2020Former FDA Director Joins Provention Bio Board Purchase Blast

Posted in: Insulin Delivery Aug 11 | 2020Medtronic to Acquire Companion Medical; Thoughts on What It Could Mean for Insulin Delivery Purchase Blast

Posted in: Glucagon, Insulin Delivery, Other Aug 10 | 2020Ascensia Takes Over WW Eversense CGM Distribution; Xeris and Senseonics Q2 '20 Earnings Update; Precigen ActoBio Announces Positive Topline Results for T1DM Modulator Purchase Blast

novo cover image

Posted in: Basal Insulin, Bolus Insulin, Dual/triple agonist, GLP-1RA, GLP-1RA + Basal, Other Aug 07 | 2020Novo Q2 '20 Roadshow; Provention Bio Q2 '20 Earnings Update; Senseonics Eversense Covered by Highmark Purchase Blast

« prev 1 … 50 51 52 53 54 … 95 next »

Get the Latest Analysis

Stay informed and aligned with frequent updates to keep a pulse on the industry.

If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact Brady.

Contact BradyLog In